Literature DB >> 23462193

Identification of nuclear factor-κB sites in the Slc2a4 gene promoter.

D T Furuya1, E A Neri, A C Poletto, G F Anhê, H S Freitas, R S Campello, N A Rebouças, U F Machado.   

Abstract

Glucose transporter GLUT4 protein, codified by Slc2a4 gene plays a key role in glycemic homeostasis. Insulin resistance, as in obesity, has been associated to inflammatory state, in which decreased GLUT4 is a feature. Inflammatory NF-κB transcriptional factor has been proposed as a repressor of Slc2a4; although, the binding site(s) in Slc2a4 promoter and the direct repressor effect have never been reported yet. A motif-based sequence analysis of mouse Slc2a4 promoter revealed two putative κB sites located inside -83/-62 and -134/-113 bp. Eletrophoretic mobility assay showed that p50 and p65 NF-κB subunits bind to both putative κB sites. Chromatin immunoprecipitation assay using genomic DNA from adipocytes confirmed p50- and p65-binding to Slc2a4 promoter. Moreover, transfection experiments revealed that NF-κB binds to the -134/-113bp region of the mouse Slc2a4 gene promoter, inhibiting the Slc2a4 gene transcription. The current findings demonstrate the existence of two κB sites in Slc2a4 gene promote, and that NF-κB has a direct repressor effect upon the Slc2a4 gene, providing an important link between insulin resistance and inflammation.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23462193     DOI: 10.1016/j.mce.2013.01.019

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

1.  Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice.

Authors:  Hannah M Davis; Alyson L Essex; Sinai Valdez; Padmini J Deosthale; Mohammad W Aref; Matthew R Allen; Andrea Bonetto; Lilian I Plotkin
Journal:  Bone       Date:  2019-04-24       Impact factor: 4.398

2.  Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy.

Authors:  Claudia Langhans; Steffen Weber-Carstens; Franziska Schmidt; Jida Hamati; Melanie Kny; Xiaoxi Zhu; Tobias Wollersheim; Susanne Koch; Martin Krebs; Herbert Schulz; Doerte Lodka; Kathrin Saar; Siegfried Labeit; Claudia Spies; Norbert Hubner; Joachim Spranger; Simone Spuler; Michael Boschmann; Gunnar Dittmar; Gillian Butler-Browne; Vincent Mouly; Jens Fielitz
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

3.  Reduced Slc2a4/GLUT4 expression in subcutaneous adipose tissue of monosodium glutamate obese mice is recovered after atorvastatin treatment.

Authors:  Ana Cláudia Poletto; Aline David-Silva; Aline Pedro de Melo Yamamoto; Ubiratan Fabres Machado; Daniela Tomie Furuya
Journal:  Diabetol Metab Syndr       Date:  2015-03-14       Impact factor: 3.320

4.  Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression.

Authors:  Danilo C Pinto-Junior; Karolline S Silva; Maria L Michalani; Caio Y Yonamine; João V Esteves; Nelly T Fabre; Karina Thieme; Sérgio Catanozi; Maristela M Okamoto; Patricia M Seraphim; Maria L Corrêa-Giannella; Marisa Passarelli; Ubiratan F Machado
Journal:  Sci Rep       Date:  2018-05-25       Impact factor: 4.379

5.  Improvement of insulin signalling rescues inflammatory cardiac dysfunction.

Authors:  Isehaq Al-Huseini; Masayuki Harada; Kiyoto Nishi; Dat Nguyen-Tien; Takeshi Kimura; Noboru Ashida
Journal:  Sci Rep       Date:  2019-10-15       Impact factor: 4.379

Review 6.  AGEs-Induced and Endoplasmic Reticulum Stress/Inflammation-Mediated Regulation of GLUT4 Expression and Atherogenesis in Diabetes Mellitus.

Authors:  Marisa Passarelli; Ubiratan Fabres Fabres Machado
Journal:  Cells       Date:  2021-12-29       Impact factor: 6.600

Review 7.  Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.

Authors:  Mariyam Khalid; Georg Petroianu; Abdu Adem
Journal:  Biomolecules       Date:  2022-04-04

8.  Resveratrol improves glycemic control in insulin-treated diabetic rats: participation of the hepatic territory.

Authors:  Caio Yogi Yonamine; Erika Pinheiro-Machado; Maria Luiza Michalani; Helayne Soares Freitas; Maristela Mitiko Okamoto; Maria Lucia Corrêa-Giannella; Ubiratan Fabres Machado
Journal:  Nutr Metab (Lond)       Date:  2016-06-29       Impact factor: 4.169

9.  Palmitate-induced Slc2a4/GLUT4 downregulation in L6 muscle cells: evidence of inflammatory and endoplasmic reticulum stress involvement.

Authors:  Patrícia Ebersbach-Silva; Ana Cláudia Poletto; Aline David-Silva; Patrícia Monteiro Seraphim; Gabriel Forato Anhê; Marisa Passarelli; Daniela Tomie Furuya; Ubiratan Fabres Machado
Journal:  Lipids Health Dis       Date:  2018-04-02       Impact factor: 3.876

10.  Diabetes Modulates MicroRNAs 29b-3p, 29c-3p, 199a-5p and 532-3p Expression in Muscle: Possible Role in GLUT4 and HK2 Repression.

Authors:  João V Esteves; Caio Y Yonamine; Danilo C Pinto-Junior; Frederico Gerlinger-Romero; Francisco J Enguita; Ubiratan F Machado
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-12       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.